Christopher Bunka - Aug 29, 2022 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)

Signature
/Chris Bunka/
Stock symbol
LEXX
Transactions as of
Aug 29, 2022
Transactions value $
$0
Form type
4
Date filed
8/29/2022, 05:18 PM
Previous filing
Sep 2, 2021
Next filing
Oct 18, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding LEXX common shares 216K Aug 29, 2022 Private Holding Company
holding LEXX common shares 274K Aug 29, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LEXX Stock Options Award $0 +30K +42.25% $0.00 101K Aug 29, 2022 Common Shares 30K $2.91 Direct
holding LEXX Warrants 6.67K Aug 29, 2022 Common Shares 6.67K $10.50 Private Holding Company
holding LEXX Stock Options 32.7K Aug 29, 2022 Common Shares 26K $5.83 Direct
holding LEXX Stock Options 56K Aug 29, 2022 Common Shares 23.3K $7.08 Direct
holding LEXX Stock Options 71K Aug 29, 2022 Common Shares 15K $6.23 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.